Dimensional Fund Advisors
ETON icon

Dimensional Fund Advisors’s Eton Pharmaceutcials ETON Stock Holding History

Dimensional Fund Advisors’s Portfolio ETON Stock Details ETON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-10,564
Closed -$34.8K – 3364
2024
Q2 		$34.8K Hold
10,564
– – ﹤0.01% 3336
2024
Q1 		$39.6K Hold
10,564
– – ﹤0.01% 3341
2023
Q4 		$46.3K Buy
+10,564
New +$42.4K ﹤0.01% 3354

Other funds holding ETON

OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return
AI
Acuitas Investments Seattle, Washington $1.43M AUM 17.52% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $9.38B AUM 33.37% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors's ETON Position: Q3 2024 in Review

Dimensional Fund Advisors sold out of Eton Pharmaceutcials (ETON) in Q3 2024, closing a stake of 10,564 shares — an estimated $34.8K sold.

Dimensional Fund Advisors first reported a position in ETON in Q4 2023 and held it in 3 quarters. The position peaked at $46.3K in Q4 2023. 48 funds tracked by Wall St. Rank hold ETON as of Q3 2024.

  • Dimensional Fund Advisors reported no remaining Eton Pharmaceutcials position as of Q3 2024 after selling out during the quarter.
  • Dimensional Fund Advisors sold 10,564 Eton Pharmaceutcials shares in Q3 2024, an estimated $34.8K.
  • Dimensional Fund Advisors first reported a position in Eton Pharmaceutcials in Q4 2023 and held it in 3 quarters.
  • Dimensional Fund Advisors's Eton Pharmaceutcials position peaked at $46.3K in Q4 2023.
  • 48 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q3 2024.

Based on Dimensional Fund Advisors's 13F filing for Q3 2024, filed 7 Nov 2024.